Ocugen or Vaxart: Which Will Take Investors Further?

Ocugen or Vaxart: Which Will Take Investors Further?

The coronavirus vaccine market is only a few months old, but it is already worth well over $1 billion. Two of them are Vaxart (NASDAQ: VXRT) and Ocugen (NASDAQ: OCGN). Both companies have recently grabbed quite a few headlines, but Ocugen has been the clear winner in terms of stock market performance since the beginning of the year, or for that matter, over the past 12 months.